2021-2030 Report on Global Biopharmaceutical CMO & CRO Market by Player, Region, Type, Application and Sales Channel

133 pages | MAResearch
This report studies the Biopharmaceutical CMO & CRO market, covering market size for segment by type (Contract Manufacturing, Contract Research, etc.), by application (Biologics, Biosimilars, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Boehringer Ingelheim, Lonza, Inno Biologics, Rentschler Biotechnologie, JRS PHARMA, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).



This report provides detailed historical analysis of global market for Biopharmaceutical CMO & CRO from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Biopharmaceutical CMO & CRO market.



Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.



This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.



The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.



Leading players of Biopharmaceutical CMO & CRO including:

Boehringer Ingelheim

Lonza

Inno Biologics

Rentschler Biotechnologie

JRS PHARMA

BIOMEVA

ProBioGen

FUJIFILM Diosynth Biotechnologies

TOYOBO

Samsung BioLogics

Thermo Fisher Scientific (Patheon)

AGC Biologics (CMC Biologics)

Binex

WuXi Biologics

AbbVie

Charles River Laboratories

ICON plc

Pharmaceutical Product Development

Laboratory Corporation of America Holdings

PAREXEL International Corporation

PRA Health Sciences

GenScript

IDTDNA

Eufin

TWIST

ABCam

BioRab

GeneWiz



Market split by Type, can be divided into:

Contract Manufacturing

Contract Research



Market split by Application, can be divided into:

Biologics

Biosimilars



Market split by Sales Channel, can be divided into:

Direct Channel

Distribution Channel



Market segment by Region/Country including:

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Spain etc.)

Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

South America (Brazil, Argentina and Colombia etc.)

Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)



If you have any special requirements, please let us know and we can provide you the customized report as you want.



Table of Contents



Chapter 1 Biopharmaceutical CMO & CRO Market Overview

1.1 Biopharmaceutical CMO & CRO Definition

1.2 Global Biopharmaceutical CMO & CRO Market Size Status and Outlook (2015-2030)

1.3 Global Biopharmaceutical CMO & CRO Market Size Comparison by Region (2015-2030)

1.4 Global Biopharmaceutical CMO & CRO Market Size Comparison by Type (2015-2030)

1.5 Global Biopharmaceutical CMO & CRO Market Size Comparison by Application (2015-2030)

1.6 Global Biopharmaceutical CMO & CRO Market Size Comparison by Sales Channel (2015-2030)

1.7 Biopharmaceutical CMO & CRO Market Dynamics (COVID-19 Impacts)

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Mergers/Acquisitions/Expansion)

1.7.4 COVID-19 Impacts on Current Market

1.7.5 Post-Strategies of COVID-19 Outbreak

Chapter 2 Biopharmaceutical CMO & CRO Market Segment Analysis by Player

2.1 Global Biopharmaceutical CMO & CRO Sales and Market Share by Player (2018-2020)

2.2 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Player (2018-2020)

2.3 Global Biopharmaceutical CMO & CRO Average Price by Player (2018-2020)

2.4 Players Competition Situation & Trends

2.5 Conclusion of Segment by Player

Chapter 3 Biopharmaceutical CMO & CRO Market Segment Analysis by Type

3.1 Global Biopharmaceutical CMO & CRO Market by Type

3.1.1 Contract Manufacturing

3.1.2 Contract Research

3.2 Global Biopharmaceutical CMO & CRO Sales and Market Share by Type (2015-2020)

3.3 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Type (2015-2020)

3.4 Global Biopharmaceutical CMO & CRO Average Price by Type (2015-2020)

3.5 Leading Players of Biopharmaceutical CMO & CRO by Type in 2020

3.6 Conclusion of Segment by Type

Chapter 4 Biopharmaceutical CMO & CRO Market Segment Analysis by Application

4.1 Global Biopharmaceutical CMO & CRO Market by Application

4.1.1 Biologics

4.1.2 Biosimilars

4.2 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Application (2015-2020)

4.3 Leading Consumers of Biopharmaceutical CMO & CRO by Application in 2020

4.4 Conclusion of Segment by Application

Chapter 5 Biopharmaceutical CMO & CRO Market Segment Analysis by Sales Channel

5.1 Global Biopharmaceutical CMO & CRO Market by Sales Channel

5.1.1 Direct Channel

5.1.2 Distribution Channel

5.2 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Sales Channel (2015-2020)

5.3 Leading Distributors/Dealers of Biopharmaceutical CMO & CRO by Sales Channel in 2020

5.4 Conclusion of Segment by Sales Channel

Chapter 6 Biopharmaceutical CMO & CRO Market Segment Analysis by Region

6.1 Global Biopharmaceutical CMO & CRO Market Size and CAGR by Region (2015-2030)

6.2 Global Biopharmaceutical CMO & CRO Sales and Market Share by Region (2015-2020)

6.3 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Region (2015-2020)

6.4 North America

6.4.1 North America Market by Country

6.4.2 North America Biopharmaceutical CMO & CRO Market Share by Type

6.4.3 North America Biopharmaceutical CMO & CRO Market Share by Application

6.4.4 United States

6.4.5 Canada

6.4.6 Mexico

6.5 Europe

6.5.1 Europe Market by Country

6.5.2 Europe Biopharmaceutical CMO & CRO Market Share by Type

6.5.3 Europe Biopharmaceutical CMO & CRO Market Share by Application

6.5.4 Germany

6.5.5 UK

6.5.6 France

6.5.7 Italy

6.5.8 Russia

6.5.9 Spain

6.6 Asia-Pacific

6.6.1 Asia-Pacific Market by Country

6.6.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Type

6.6.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Application

6.6.4 China

6.6.5 Japan

6.6.6 Korea

6.6.7 India

6.6.8 Southeast Asia

6.6.9 Australia

6.7 South America

6.7.1 South America Market by Country

6.7.2 South America Biopharmaceutical CMO & CRO Market Share by Type

6.7.3 South America Biopharmaceutical CMO & CRO Market Share by Application

6.7.4 Brazil

6.7.5 Argentina

6.7.6 Colombia

6.8 Middle East & Africa

6.8.1 Middle East & Africa Market by Country

6.8.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Type

6.8.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Application

6.8.4 UAE

6.8.5 Saudi Arabia

6.8.6 South Africa

6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Biopharmaceutical CMO & CRO Players

7.1 Boehringer Ingelheim

7.1.1 Company Snapshot

7.1.2 Product/Service Offered

7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

7.1.4 COVID-19 Impact on Boehringer Ingelheim

7.2 Lonza

7.3 Inno Biologics

7.4 Rentschler Biotechnologie

7.5 JRS PHARMA

7.6 BIOMEVA

7.7 ProBioGen

7.8 FUJIFILM Diosynth Biotechnologies

7.9 TOYOBO

7.10 Samsung BioLogics

7.11 Thermo Fisher Scientific (Patheon)

7.12 AGC Biologics (CMC Biologics)

7.13 Binex

7.14 WuXi Biologics

7.15 AbbVie

7.16 Charles River Laboratories

7.17 ICON plc

7.18 Pharmaceutical Product Development

7.19 Laboratory Corporation of America Holdings

7.20 PAREXEL International Corporation

7.21 PRA Health Sciences

7.22 GenScript

7.23 IDTDNA

7.24 Eufin

7.25 TWIST

7.26 ABCam

7.27 BioRab

7.28 GeneWiz

Chapter 8 Upstream and Downstream Analysis of Biopharmaceutical CMO & CRO

8.1 Industrial Chain of Biopharmaceutical CMO & CRO

8.2 Upstream of Biopharmaceutical CMO & CRO

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.2.4 Manufacturing Cost Structure

8.2.5 Manufacturing Process

8.3 Downstream of Biopharmaceutical CMO & CRO

8.3.1 Leading Distributors/Dealers of Biopharmaceutical CMO & CRO

8.3.2 Leading Consumers of Biopharmaceutical CMO & CRO

Chapter 9 Development Trend of Biopharmaceutical CMO & CRO (2021-2030)

9.1 Global Biopharmaceutical CMO & CRO Market Size (Sales and Revenue) Forecast (2021-2030)

9.2 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Region (2021-2030)

9.3 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Type (2021-2030)

9.4 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Application (2021-2030)

9.5 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Sales Channel (2021-2030)

Chapter 10 Appendix

10.1 Research Methodology

10.2 Data Sources

10.3 Disclaimer

10.4 Analysts Certification



Enquire before buy

relatedReports

Purchase this Report
Please select buying option
Single User $2500
Multi User $3750
Enterprise $5000

Newsletters Signup

Sign up to Our Newsletter & get attractive Offers by subscribing to our newsletters.

Thank you for suscrbing!